8
Oct
2024

Anhui Poly Pharm Co.,Ltd

Exhibitor at CPHI Milan 2024 stand 1C86, API
About Us

Anhui Poly Pharm Co., Ltd. founded in 2018, is a whol-ly-owned subsidiary of Hainan Poly Pharm Co. Ltd.,  We have established strietcGMP quality system complying with US and EU requirements,.We have already put 3 APl production workshops  into use, with10 production lines and 357 multi-functional equipment. In 2023,our APl producetion lines respectively for Gadoterate Meglumineand Cyclophosphamide passed the FDA on-site inspection., we have launch the production o f3 safest MRI contrast agents,the validation batches of Semaglutide. Antitumor products.

  • CN
  • 2023
    On CPHI since
  • 500 - 999
    Employees
Company types
Pharmaceutical company
Contact info
  • No.58 Xiahong Rd, High-tech Industrial Dev Area, 24600, Anqing City, Anhui province, China
Event information
CPHI Milan 2024
  • 08 Oct 2024 - 10 Oct 2024
  • Fiera Milano, Italy
  • Visit us at stand 1C86, API

Products Featured at CPHI Milan 2024

  • Cyclophosphamide

    Product Cyclophosphamide

    CDE: A       DMF No.: 037154        CEP:under review , Q3 2024ASMF available
  • Gadobutrol

    Product Gadobutrol

    CDE: I         DMF No.: 039149   CEP/ASMF:  Q2 2025
  • Gadoterate Meglumine

    Product Gadoterate Meglumine

    CDE: A        DMF No.: 037072    ASMF available   
  • Glycopyrrolate

    Product Glycopyrrolate

    CDE: A      DMF No.: 035446   R0-CEP 2021-154-Rev 00
  • Semaglutide

    Product Semaglutide

    DMF/ASMF: Q3   2024 CEP:   Q3 2024